Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

RedotPay has announced a new partnership with Ripple to improve its stablecoin payout infrastructure and broaden access to lower-cost cross-border transactions.

EUR/NGN: The British Pound is largely unmoved against the Euro and US Dollar on Tuesday after UK labour market figures revealed a rise in unemployment and slower wage growth, reinforcing market bets ...

Welcome to the 2016 USD NGN history summary. This is the US Dollar (USD) to Nigerian Naira (NGN) exchange rate history data page for the year of 2016, covering 366 days of USD NGN historical data.

Rupert Murdoch‘s News Group Newspapers (NGN) has made a shock apology to Prince Harry and the pair have settled in court. In the past few minutes, the BBC reported NGN apologizing for phone hacking, ...

RedotPay partners with Ripple to offer an instant crypto-to-Naira payout feature with faster settlement and lower costs.

NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, ...

EXTON, Pa., July 22, 2025 /PRNewswire/ -- White Label Communications (WLC), the market-leading provider of white-label UCaaS, CPaaS, and CCaaS solutions, today announced the acquisition of Grupo NGN, ...

Neurogene (NASDAQ:NGNE) shares plunged 36% Monday after the company issued an update on a Phase 1/2 study of its gene therapy NGN-401 for Rhett syndrome. Neurogene (NGNE) said that a patient who had ...

Written agreement from FDA for single-arm, open-label, baseline-controlled registrational trial evaluating composite primary endpoint of improvement in CGI-I and gain of developmental milestone/skill ...

An announcement from Neurogene ( (NGNE)) is now available. On November 12, 2025, Neurogene Inc. announced positive interim clinical data from its Phase 1/2 trial of NGN-401 gene therapy for females ...